troglitazone has been researched along with Cardiovascular Stroke in 4 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, TM | 1 |
| Chou, TF | 1 |
| Epstein, RA | 1 |
| Chintalgattu, V | 1 |
| Harris, GS | 1 |
| Akula, SM | 1 |
| Katwa, LC | 1 |
| Sternon, J | 1 |
1 review available for troglitazone and Cardiovascular Stroke
| Article | Year |
|---|---|
[Post myocardial infarction management].
Topics: Aftercare; Anticholesteremic Agents; Antioxidants; Atorvastatin; Chromans; Clopidogrel; Diet, Fat-Re | 1997 |
3 other studies available for troglitazone and Cardiovascular Stroke
| Article | Year |
|---|---|
Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins.
Topics: Animals; Blood Glucose; Blotting, Western; Cardiotonic Agents; Chromans; Connexin 43; Dogs; Dose-Res | 2003 |
Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chromans; Clinical Trials as Topic; Cyclooxygena | 2005 |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
Topics: Animals; Cells, Cultured; Chromans; Collagen; Drug Combinations; Enzyme-Linked Immunosorbent Assay; | 2007 |